Scimega Research was founded to meet the industry’s demand for superior clinical trial management services in the complex field of oncology clinical research. Our mission is to attract cutting-edge oncology compounds and clinical trials to Canada, and to connect drug developers with a network of highly motivated investigators and their patients. The Reverse Feasibility Program is a collaborative network of Canada's top performing medical oncologists that routinely share their academic interests and clinical trial needs in an effort to assist us in promoting Canada's oncology clinical research capabilities.